PierottiMABerrinoFGariboldiM. Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects. Oncogene. 2013;32
(12):1475–1487.
2.
BersteinLM. Metformin in obesity, cancer and aging: addressing controversies. Aging (Albany NY). 2012;4
(5):320–329.
3.
Andujar-PlataPPi-SunyerXLaferrereB. Metformin effects revisited. Diabetes Res Clin Pract. 2012;95
(1):1–9.
GoodwinPJThompsonAMStambolicV. Diabetes, metformin, and breast cancer: lilac time?J Clin Oncol. 2012;30
(23):2812–2814.
6.
WernerEBellJ. The preparation of methylguanidine and of β, β-dimethylguanidine by the interaction of dicyanidiamide and methyl ammonium and dimethylammonium chlorides respectively. J Chem Soc Trans. 1922;121:1790–1794.
7.
Del BarcoSVazquez-MartinACufiS. Metformin: multi-faceted protection against cancer. Oncotarget. 2011;2
(12):896–917.
8.
PernicovaIKorbonitsM. Metformin—mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol. 2014;10
(3):143–156.
9.
GallagherEJLeRoithD. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation. Ann N Y Acad Sci. 2011;1243:54–68.
10.
JalvingMGietemaJALefrandtJD. Metformin: taking away the candy for cancer?Eur J Cancer. 2010;46
(13):2369–2380.
11.
GiovannucciEHarlanDMArcherMC. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674–1685.
